Free Trial

atai Life Sciences (ATAI) Short Interest Ratio & Short Volume

atai Life Sciences logo
$4.58 -0.07 (-1.51%)
Closing price 04:00 PM Eastern
Extended Trading
$4.55 -0.03 (-0.66%)
As of 06:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

atai Life Sciences Short Interest Data

atai Life Sciences (ATAI) has a short interest of 15.84 million shares, representing 11.56% of the float (the number of shares available for trading by the public). This marks a -2.10% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.1, indicating that it would take 3.1 days of the average trading volume of 3.82 million shares to cover all short positions.

Current Short Interest
15,840,000 shares
Previous Short Interest
16,180,000 shares
Change Vs. Previous Month
-2.10%
Dollar Volume Sold Short
$64.94 million
Short Interest Ratio
3.1 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
214,340,000 shares
Float Size
137,080,000 shares
Short Percent of Float
11.56%
Today's Trading Volume
3,089,445 shares
Average Trading Volume
3,822,585 shares
Today's Volume Vs. Average
81%
Short Selling atai Life Sciences?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for atai Life Sciences and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

ATAI Short Interest Over Time

ATAI Days to Cover Over Time

ATAI Percentage of Float Shorted Over Time

atai Life Sciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202515,840,000 shares $64.94 million -2.1%11.6%3.1 $4.10
7/15/202516,180,000 shares $42.88 million +58.8%11.8%4 $2.65
6/30/202510,190,000 shares $22.32 million -7.0%7.4%3.1 $2.19
6/15/202510,960,000 shares $23.13 million -5.1%8.0%5 $2.11
5/31/202511,550,000 shares $26.22 million -9.7%8.4%5.7 $2.27
5/15/202512,790,000 shares $20.85 million +4.9%9.5%6.7 $1.63
4/30/202512,190,000 shares $18.29 million +0.4%9.0%5.1 $1.50
4/15/202512,140,000 shares $16.87 million +3.9%8.9%4.4 $1.39
3/31/202511,680,000 shares $15.88 million +12.3%8.6%4.2 $1.36
3/15/202510,400,000 shares $15.39 million -5.1%7.8%3.8 $1.48
2/28/202510,960,000 shares $18.85 million -1.8%8.3%4.1 $1.72
2/15/202511,160,000 shares $25.67 million -1.3%8.9%4.3 $2.30
1/31/202511,310,000 shares $17.53 million -2.1%9.7%4.8 $1.55
1/15/202511,550,000 shares $16.63 million +7.5%9.9%6.9 $1.44
12/31/202410,740,000 shares $14.28 million +1.2%9.2%6.6 $1.33
12/15/202410,610,000 shares $14.43 million +4.0%9.1%7.9 $1.36
11/30/202410,200,000 shares $18.16 million +3.3%8.7%8.4 $1.78
11/15/20249,870,000 shares $15.89 million +4.7%8.4%8.8 $1.61
10/31/20249,430,000 shares $10.00 million -1.7%8.1%12.5 $1.06
10/15/20249,590,000 shares $10.45 million +1.2%8.2%16 $1.09
9/30/20249,480,000 shares $11.00 million -1.6%8.1%15.8 $1.16
9/15/20249,630,000 shares $12.52 million +9.7%8.2%15.4 $1.30
8/31/20248,780,000 shares $11.41 million -8.3%7.5%12.7 $1.30
8/15/20249,570,000 shares $11.96 million +9.0%8.2%12 $1.25
7/31/20248,780,000 shares $13.61 million -5.4%7.5%10.7 $1.55
7/15/20249,280,000 shares $14.94 million +11.5%8.0%10.4 $1.61
6/30/20248,320,000 shares $11.07 million +5.1%7.1%8.4 $1.33
6/15/20247,920,000 shares $10.85 million +14.8%6.8%5.8 $1.37
5/31/20246,900,000 shares $10.83 million +12.9%5.9%4.8 $1.57
5/15/20246,110,000 shares $12.53 million -3.2%5.3%4 $2.05
4/30/20246,310,000 shares $12.49 million +7.0%5.4%4 $1.98
4/15/20245,900,000 shares $12.21 million +6.3%5.1%3.7 $2.07
3/31/20245,550,000 shares $10.93 million +6.5%4.8%3.2 $1.97
3/15/20245,210,000 shares $9.22 million +47.6%4.5%3.5 $1.77
2/29/20243,530,000 shares $6.85 million -27.5%3.0%2.5 $1.94
2/15/20244,870,000 shares $8.77 million +2.5%4.2%3.7 $1.80
1/31/20244,750,000 shares $8.46 million +7.7%4.2%3.8 $1.78
1/15/20244,410,000 shares $8.64 million +1.9%3.9%3.9 $1.96
12/31/20234,330,000 shares $6.11 million -4.2%3.8%4.3 $1.41
12/15/20234,520,000 shares $5.70 million -6.6%4.0%6.1 $1.26
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel

All the details are waiting for you now — but you need to act before the September 1st funding windo
11/30/20234,840,000 shares $5.03 million -4.9%4.2%7.8 $1.04
11/15/20235,090,000 shares $6.11 million -9.6%4.5%9.7 $1.20
10/31/20235,630,000 shares $6.92 million +20.6%4.9%11.1 $1.23
10/15/20234,670,000 shares $5.98 million -0.6%4.1%8.7 $1.28
9/30/20234,700,000 shares $6.06 million +3.3%4.1%6.4 $1.29
9/15/20234,550,000 shares $6.60 million +10.4%4.0%5.3 $1.45
8/31/20234,120,000 shares $6.30 million -0.2%3.6%4.3 $1.53
8/15/20234,130,000 shares $6.65 million +1.0%3.6%4.2 $1.61
7/31/20234,090,000 shares $8.55 million +0.3%3.6%4.1 $2.09
7/15/20234,080,000 shares $8.24 million -9.7%3.5%3.9 $2.02
6/30/20234,520,000 shares $7.77 million -6.4%3.9%4.2 $1.72
6/15/20234,830,000 shares $8.65 million -2.8%4.2%4.3 $1.79
5/31/20234,970,000 shares $8.90 million -2.9%4.3%4.6 $1.79
5/15/20235,120,000 shares $10.24 million -3.4%4.4%4.5 $2.00
4/30/20235,300,000 shares $10.12 million +6.2%4.6%4.4 $1.91
4/15/20234,990,000 shares $9.38 million +3.1%4.3%3.8 $1.88
3/31/20234,840,000 shares $8.76 million +14.4%4.1%3.4 $1.81
3/15/20234,230,000 shares $5.20 million +3.9%3.5%3.1 $1.23
2/28/20234,070,000 shares $6.84 million +5.2%3.3%3 $1.68
2/15/20233,870,000 shares $6.97 million -14.0%3.2%2.8 $1.80
1/31/20234,500,000 shares $8.01 million -24.6%3.7%3 $1.78
1/15/20235,970,000 shares $10.75 million +1.5%4.9%4.3 $1.80
12/30/20225,880,000 shares $15.64 million +7.5%4.8%4.8 $2.66
12/15/20225,470,000 shares $16.74 million +9.2%4.5%5.7 $3.06
11/30/20225,010,000 shares $17.69 million +5.5%4.1%5.7 $3.53
11/15/20224,750,000 shares $13.68 million -13.2%3.9%5.6 $2.88
10/31/20225,470,000 shares $16.14 million -12.9%4.5%7.8 $2.95
10/15/20226,280,000 shares $18.90 million -2.0%5.2%8.8 $3.01
9/30/20226,410,000 shares $21.22 million -1.1%5.3%8.6 $3.31
9/15/20226,480,000 shares $26.83 million +0.9%5.5%8.4 $4.14
8/31/20226,420,000 shares $28.89 million +3.6%5.5%8.1 $4.50
8/15/20226,200,000 shares $29.02 million +9.7%5.3%7.5 $4.68
7/31/20225,650,000 shares $21.81 million +9.9%4.8%6.5 $3.86
7/15/20225,140,000 shares $21.85 million -13.5%4.4%6.1 $4.25
6/30/20225,940,000 shares $21.62 million +35.6%5.1%7.3 $3.64
6/15/20224,380,000 shares $14.50 million +9.0%3.8%5.1 $3.31
5/31/20224,020,000 shares $16.00 million +1.8%3.4%4.6 $3.98
5/15/20223,950,000 shares $14.38 million +21.5%3.4%4.7 $3.64
4/30/20223,250,000 shares $13.94 million +10.9%2.8%3.8 $4.29
4/15/20222,930,000 shares $15.59 million +4.3%2.5%3.4 $5.32
3/31/20222,810,000 shares $14.30 million -11.9%2.4%2.9 $5.09
3/15/20223,190,000 shares $15.76 million +8.1%2.7%3.3 $4.94
2/28/20222,950,000 shares $16.93 million -9.0%2.5%2.6 $5.74
2/15/20223,240,000 shares $19.12 million -17.8%2.7%2.9 $5.90
1/31/20223,940,000 shares $21.00 million +14.5%3.3%3.7 $5.33
1/15/20223,440,000 shares $20.50 million -19.4%2.9%3.4 $5.96
12/31/20214,270,000 shares $32.58 million +50.9%3.7%4.8 $7.63
12/15/20212,830,000 shares $19.30 million +25.2%2.4%3.7 $6.82
11/30/20212,260,000 shares $24.81 million +11.3%2.0%5 $10.98
11/15/20212,030,000 shares $26.09 million -1.0%1.8%4.9 $12.85
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel

All the details are waiting for you now — but you need to act before the September 1st funding windo
10/29/20212,050,000 shares $29.91 million +0.5%1.9%5.8 $14.59
10/15/20212,040,000 shares $27.54 million +2.0%1.9%6.7 $13.50
9/30/20212,000,000 shares $29.58 million +16.3%1.8%6.3 $14.79
9/15/20211,720,000 shares $26.13 million +10.3%1.6%5 $15.19
8/31/20211,560,000 shares $25.55 million +14.7%1.4%2.9 $16.38
8/13/20211,360,000 shares $18.52 million No Change1.2%2.2 $13.62

ATAI Short Interest - Frequently Asked Questions

What is atai Life Sciences' current short interest?

Short interest is the volume of atai Life Sciences shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 15,840,000 shares of ATAI short. 11.56% of atai Life Sciences' shares are currently sold short. Learn More on atai Life Sciences' current short interest.

What is a good short interest ratio for atai Life Sciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATAI shares currently have a short interest ratio of 3.0. Learn More on atai Life Sciences's short interest ratio.

Which institutional investors are shorting atai Life Sciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of atai Life Sciences: Group One Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for atai Life Sciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.56% of atai Life Sciences' floating shares are currently sold short.

Is atai Life Sciences' short interest increasing or decreasing?

atai Life Sciences saw a drop in short interest in July. As of July 31st, there was short interest totaling 15,840,000 shares, a drop of 2.1% from the previous total of 16,180,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is atai Life Sciences' float size?

atai Life Sciences currently has issued a total of 214,340,000 shares. Some of atai Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. atai Life Sciences currently has a public float of 137,080,000 shares.

How does atai Life Sciences' short interest compare to its competitors?

11.56% of atai Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to atai Life Sciences: ADMA Biologics Inc (5.96%), Vaxcyte, Inc. (10.57%), PTC Therapeutics, Inc. (8.02%), Lantheus Holdings, Inc. (12.75%), Arcellx, Inc. (16.18%), Zai Lab Limited Unsponsored ADR (4.33%), Akero Therapeutics, Inc. (10.92%), Mirum Pharmaceuticals, Inc. (15.41%), Protagonist Therapeutics, Inc. (9.74%), MoonLake Immunotherapeutics (11.00%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short atai Life Sciences stock?

Short selling ATAI is an investing strategy that aims to generate trading profit from atai Life Sciences as its price is falling. ATAI shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against atai Life Sciences?

A short squeeze for atai Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATAI, which in turn drives the price of the stock up even further.

How often is atai Life Sciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATAI, twice per month. The most recent reporting period available is July, 31 2025.




This page (NASDAQ:ATAI) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners